Golden Valley Development, Inc (GVDI)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -141.81 Thousand USD | -9.09% |
| 2022 | -130 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | -2.56 Million USD | -703.98% |
| 2014 | -319.59 Thousand USD | -1853.01% |
| 2013 | -16.36 Thousand USD | 0.0% |
| 2011 | -92.52 Thousand USD | 45.48% |
| 2010 | -169.72 Thousand USD | 8.25% |
| 2009 | -184.99 Thousand USD | -608.2% |
| 2008 | -26.12 Thousand USD | 6.86% |
| 2007 | -28.04 Thousand USD | -9.49% |
| 2006 | -25.61 Thousand USD | -63.59% |
| 2005 | -15.65 Thousand USD | -380.09% |
| 2004 | 5590.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -35.79 Thousand USD | 2.98% |
| 2024 Q1 | -36.89 Thousand USD | -4.96% |
| 2023 Q4 | -35.15 Thousand USD | 4.09% |
| 2023 FY | -141.81 Thousand USD | -9.09% |
| 2023 Q1 | -35.75 Thousand USD | 0.0% |
| 2023 Q2 | -34.25 Thousand USD | 4.2% |
| 2023 Q3 | -36.65 Thousand USD | -7.01% |
| 2022 FY | -130 Thousand USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2016 Q1 | -1.09 Million USD | -11.95% |
| 2015 Q1 | -108.88 Thousand USD | 99.91% |
| 2015 Q3 | -67.7 Thousand USD | 95.21% |
| 2015 Q4 | -978.08 Thousand USD | -1344.7% |
| 2015 FY | -2.56 Million USD | -703.98% |
| 2015 Q2 | -1.41 Million USD | -1199.37% |
| 2014 FY | -319.59 Thousand USD | -1853.01% |
| 2014 Q4 | -119.86 Million USD | 0.0% |
| 2013 FY | -16.36 Thousand USD | 0.0% |
| 2011 FY | -92.52 Thousand USD | 45.48% |
| 2010 Q1 | -2842.00 USD | 98.28% |
| 2010 FY | -169.72 Thousand USD | 8.25% |
| 2010 Q2 | -2842.00 USD | 0.0% |
| 2009 Q1 | -6046.00 USD | -45.34% |
| 2009 Q4 | -165.14 Thousand USD | -2592.31% |
| 2009 FY | -184.99 Thousand USD | -608.2% |
| 2009 Q3 | -6134.00 USD | 27.54% |
| 2009 Q2 | -8465.00 USD | -40.01% |
| 2008 FY | -26.12 Thousand USD | 6.86% |
| 2008 Q4 | -4160.00 USD | 40.34% |
| 2008 Q3 | -6973.00 USD | -104.73% |
| 2008 Q2 | -3406.00 USD | 70.59% |
| 2008 Q1 | -11.58 Thousand USD | 45.95% |
| 2007 Q2 | -880.00 USD | 66.26% |
| 2007 Q1 | -2608.00 USD | 23.94% |
| 2007 Q3 | -3128.00 USD | -255.45% |
| 2007 Q4 | -21.42 Thousand USD | -585.07% |
| 2007 FY | -28.04 Thousand USD | -9.49% |
| 2006 Q4 | -3429.00 USD | 16.61% |
| 2006 Q2 | -1597.00 USD | 83.43% |
| 2006 Q1 | -9639.00 USD | -457.49% |
| 2006 Q3 | -4112.00 USD | -157.48% |
| 2006 FY | -25.61 Thousand USD | -63.59% |
| 2005 FY | -15.65 Thousand USD | -380.09% |
| 2005 Q3 | -5859.00 USD | 30.53% |
| 2005 Q4 | -1729.00 USD | 70.49% |
| 2005 Q2 | -8434.00 USD | 0.0% |
| 2004 FY | 5590.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 84.7% |
| Ansell Limited | 76.5 Million USD | 100.185% |
| Ansell Limited | 76.5 Million USD | 100.185% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 100.584% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 91.301% |
| Psykey, Inc. | -1.32 Million USD | 89.289% |
| ConvaTec Group Plc | 130.3 Million USD | 100.109% |
| ConvaTec Group Plc | 130.3 Million USD | 100.109% |
| Encision Inc. | -691.78 Thousand USD | 79.501% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 39.492% |
| Innovative MedTech Inc. | -7.93 Million USD | 98.214% |
| LifePoint, Inc. | -15.23 Million USD | 99.069% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 97.918% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 70.082% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 48.328% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 69.106% |
| SmileDirectClub, Inc. | -86.4 Million USD | 99.836% |
| Sector 10, Inc. | 7036.00 USD | 2115.506% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.007% |
| SheerVision, Inc. | -71.37 Thousand USD | -98.682% |
| United Health Products, Inc. | -2.62 Million USD | 94.594% |
| Vasamed, Inc. | -4.88 Million USD | 97.099% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 94.063% |
| Yubo International Biotech Limited | -1.2 Million USD | 88.229% |